(Q36999374)

17 August 2017

Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer (English)

1 reference

17 August 2017

metastatic breast cancer

1 reference

inferred from title

author

Ioannis A. Voutsadakis

series ordinal

2

object named as

Ioannis A Voutsadakis

1 reference

17 August 2017

Athina Stravodimou

1

1 reference

17 August 2017

24 June 2013

1 reference

International Journal of Breast Cancer

17 August 2017

1 reference

17 August 2017

2013

1 reference

17 August 2017

289563

1 reference

Creative Commons Attribution 3.0 Unported

17 August 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Adjuvant systemic therapies in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Paraneoplastic thrombocytosis in ovarian cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Tumor-platelet interaction in solid tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

How platelets safeguard vascular integrity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarker

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Contribution of platelets to tumour metastasis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Innate immune cells induce hemorrhage in tumors during thrombocytopenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

The basics of epithelial-mesenchymal transition

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Poor prognosis associated with thrombocytosis in patients with cervical cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Poor prognosis associated with thrombocytosis in patients with gastric cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707237

Poor Prognosis Associated With Thrombocytosis in Patients With Gastric Cancer

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2013%2F289563

Impact of pretreatment thrombocytosis on survival in primary breast cancer

21 January 2018

1 reference

12 December 2020

Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood

1 reference

12 December 2020

Serum interleukin 6 as a prognostic factor in patients with prostate cancer

1 reference

12 December 2020

THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE

1 reference

12 December 2020

Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/289563

1 reference

17 August 2017

1 reference

PMC publication ID

3707237

17 August 2017

PubMed publication ID

23864954

1 reference

PMC publication ID

3707237